Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
A BILL
To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Sec. 2 Medicare coverage of multi-cancer early detection screening tests
“(KK) multi-cancer early detection screening tests (as defined in subsection (nnn));”
“(nnn) Multi-Cancer early detection screening tests
“(1) In general—The term multi-cancer early detection screening test means a test furnished to an individual for the concurrent detection of multiple cancer types across multiple organ sites on or after January 1, 2028, that—
“(A) is cleared under section 510(k), classified under section 513(f)(2), or approved under section 515 of the Federal Food, Drug, and Cosmetic Act;
“(B) is—
“(i) a genomic sequencing blood or blood product test that includes the analysis of cell-free nucleic acids; or
“(ii) a test based on samples of biological material that provides results comparable to those obtained with a test described in clause (i), as determined by the Secretary; and
“(C) the Secretary determines is—
“(i) reasonable and necessary for the prevention or early detection of an illness or disability; and
“(ii) appropriate for individuals entitled to benefits under part A or enrolled under part B.
“(2) NCD process—In making determinations under paragraph (1)(C) regarding the coverage of a new test, the Secretary shall use the process for making national coverage determinations (as defined in section 1869(f)(1)(B)) under this title.”
“(aa) Payment and standards for multi-Cancer early detection screening tests
“(1) Payment amount—The payment amount for a multi-cancer early detection screening test (as defined in section 1861(nnn)) is—
“(A) with respect to such a test furnished before January 1, 2031, equal to the payment amount in effect on the date of the enactment of this subsection for a multi-target stool screening DNA test covered pursuant to section 1861(pp)(1)(D); and
“(B) with respect to such a test furnished on or after January 1, 2031, equal to the lesser of—
“(i) the amount described in subparagraph (A); or
“(ii) the payment amount determined for such test under section 1834A.
“(2) Limitations
“(A) In general—No payment may be made under this part for a multi-cancer early detection screening test furnished during a year to an individual if—
“(i) as of January 1 of such year, such individual has attained the age specified in subparagraph (B) for such year; or
“(ii) such a test was furnished to the individual during the previous 11 months.
“(B) Age specified—For purposes of subparagraph (A)(i), the age specified in this subparagraph is—
“(i) for 2028, 68 years of age; and
“(ii) for a succeeding year, the age specified in this subparagraph for the preceding year, increased by 1 year.
“(3) Standards following USPSTF rating—In the case of a multi-cancer early detection screening test that is recommended with a grade of A or B by the United States Preventive Services Task Force, beginning on the date on which coverage for such test is provided pursuant to section 1861(ddd)(1), the preceding provisions of this subsection shall not apply.”
“(Q) in the case of multi-cancer early detection screening tests (as defined in section 1861(nnn)), which are not reasonable and necessary for the concurrent detection of multiple cancer types across multiple organ sites;”